Er-Kim Leads Pharma & Cosmetics Sector; Places #6 Overall in Bulgaria’s Premier Business Ranking

Capital’s Cheetah ranking recognizes the rapidly growing and most resilient SMEs in Bulgaria’s economy

SOPHIA, SOPHIA, BULGARIA, March 18, 2026 /EINPresswire.com/ -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in the EMEA region, is proud to announce its top-tier placement in the latest Cheetah ranking by Capital, Bulgaria’s premier business news outlet. The Cheetah ranking identifies the fastest-growing and most resilient companies in the region. Tracking the growth dynamics of small and medium-sized enterprises (SMEs), the report placed Er-Kim first in the Pharmacy and Cosmetics sector and an impressive sixth in the overall national ranking of the top 100 companies in Bulgaria.

This recognition highlights Er-Kim’s rapid expansion and its pivotal role during a critical period for the Bulgarian healthcare system. While many global pharmaceutical entities are scaling back their physical presence in the country due to pricing regulations and market size, Er-Kim has doubled down on its commitment to the region. The company has distinguished itself as the partner of choice for biotechs looking to enter Central & Eastern Europe (CEE) by bridging the gap between global biotech innovation and patient access.

Cem Zorlular, Chief Executive Officer of Er-Kim, said, “Securing the top spot in our sector and ranking among the top ten companies nationally is a testament to our team’s dedication to bringing life-changing treatments not just to Bulgaria, but to all of Central & Eastern Europe. In an era where domestic markets face mounting pricing and regulatory pressures, our Day 1 global strategy ensures that Bulgarian patients have immediate access to the same medical breakthroughs available in the US and Western Europe.”

Er-Kim’s growth in Bulgaria is driven by a robust portfolio of strategic partnerships with global leaders. By navigating complex regulatory environments and establishing a sophisticated local infrastructure, Er-Kim ensures critical treatments in oncology, rare diseases, and specialty care reach patients worldwide.
The Capital Cheetah report is highly regarded as a definitive barometer of business health in Bulgaria, focusing on companies that demonstrate sustainable revenue growth over two consecutive years and meet strict private ownership and financial transparency criteria.

About Er-Kim
Established in 1981, Er-Kim stands at the forefront of biopharmaceutical innovation, setting new commercialization and patient access standards. Through strategic partnerships with over 40 global leaders, Er-Kim distributes more than 68 products to 50+ countries, revolutionizing patient care in international markets by solving complex distribution challenges. Er-Kim has a dedicated team of over 400 professionals worldwide and revenues exceeding EUR 390M. For more information, please visit www.er-kim.com.

Rosalia Scampoli
Marketcom PR
+1 914-815-1465
rscampoli@marketcompr.com
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.